Breast Cancer Experience of the Molecular Tumor Board at the University of California, San Diego Moores Cancer Center-Reference-Cited by-同舟云学术

Breast Cancer Experience of the Molecular Tumor Board at the University of California, San Diego Moores Cancer Center

Published:2015-11 Issue:6 Volume:11 Page:442-449
ISSN:1554-7477
Container-title:Journal of Oncology Practice
language:en
Short-container-title:JOP

Author:

Parker Barbara A.¹,Schwaederlé Maria¹,Scur Michael D.¹,Boles Sarah G.¹,Helsten Teresa¹,Subramanian Rupa¹,Schwab Richard B.¹,Kurzrock Razelle¹

Affiliation:

1. Center for Personalized Cancer Therapy, Moores Cancer Center, University of California, San Diego, La Jolla, CA

Abstract

Multidisciplinary molecular tumor boards may help optimize the management of patients with advanced, heavily pretreated breast cancer who have undergone genomic testing.

Publisher

American Society of Clinical Oncology (ASCO)

Subject

Health Policy,Oncology (nursing),Oncology

Link

https://ascopubs.org/doi/pdfdirect/10.1200/JOP.2015.004127

Reference24 articles.

1. A Targeted Next-Generation Sequencing Assay Detects a High Frequency of Therapeutically Targetable Alterations in Primary and Metastatic Breast Cancers: Implications for Clinical Practice

2. Unique molecular signatures as a hallmark of patients with metastatic breast cancer: Implications for current treatment paradigms

3. Mutation profiling identifies numerous rare drug targets and distinct mutation patterns in different clinical subtypes of breast cancers

4. Combined analysis of gene expression, DNA copy number, and mutation profiling data to display biological process anomalies in individual breast cancers

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Molecular Tumor Board for Unicorns: Outcomes for rare and ultra-rare cancers using an N-of-One personalized treatment strategy;iScience;2024-08

2. Präzisionsonkologie, molekulares Tumorboard und translationale Programme beim metastasierten Mammakarzinom;Die Onkologie;2024-04-25

3. NGS-Guided Precision Oncology in Breast Cancer and Gynecological Tumors—A Retrospective Molecular Tumor Board Analysis;Cancers;2024-04-19

4. Virtual multi-institutional tumor board: a strategy for personalized diagnoses and management of rare CNS tumors;Journal of Neuro-Oncology;2024-03-01

5. The Diversity of Liquid Biopsies and Their Potential in Breast Cancer Management;Cancers;2023-11-17